First AI-based medical device gains government approval in South Korea

South Korea’s Ministry of Food and Drug Safety announced this week that, for the very first time, it has approved a medical device that uses artificial intelligence (AI) technology.

The device, VUNO’s VUNOmed-BoneAge, was developed to determine a patient’s bone age by studying x-ray images, according to a report from Korea Biomedical Review. The approval came after a clinical trial confirmed the device’s effectiveness.  

“Both the company and the ministry expect the invention will shorten the reading time by automating the manual reading of the bone age,” wrote author Lee Han-soo.

Korea Biomedical Review also reported that three other medical devices related to AI and big data are currently going through clinical trials.

Click below to read the full story.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.